
Terrain Biosciences
AI-driven mRNA design and manufacturing for rapid RNA therapeutics development.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | $9.0m | Seed | |
Total Funding | 000k |
Related Content
Terrain BioSciences specializes in the design and manufacturing of mRNA sequences, catering primarily to RNA therapeutics companies. Operating in the biotech hub of Cambridge, MA, the company leverages advanced AI models and a cutting-edge manufacturing platform to deliver high-quality RNA materials. Terrain BioSciences focuses on accelerating the development of RNA medicines by providing scalable mRNA production from microgram to gram scale. The business model revolves around partnering with clients to optimize RNA sequences, thereby reducing experimental timelines and costs. The company's revenue is generated through the provision of these specialized services, which are crucial for translational studies and clinical advancements. Key clients include biotech firms engaged in RNA-based drug discovery and development. Keywords: mRNA, RNA therapeutics, AI models, manufacturing, biotech, Cambridge, scalable production, RNA design, translational studies, clinical advancements.